3,201–3,250 of 20,598 genesranked by Most Researched
| # | Gene | Name | Chr | Tags | PubMed Papers |
|---|---|---|---|---|---|
| 3201 | PCCA | propionyl-CoA carboxylase subunit alpha | 13 | OMIM Disease GeneVariant-Rich | 143 |
| 3202 | PFDN2 | prefoldin subunit 2 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 143 |
| 3203 | PIAS3 | protein inhibitor of activated STAT 3 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 143 |
| 3204 | PKLR | pyruvate kinase L/R | 1 | Hub GeneKinase | 143 |
| 3205 | SF3A2 | splicing factor 3a subunit 2 | 19 | Highly ConstrainedHub Gene | 143 |
| 3206 | SLC22A2 | solute carrier family 22 member 2 | 6 | TransporterExperimental GO Evidence | 143 |
| 3207 | SLC25A10 | solute carrier family 25 member 10 | 17 | TransporterOMIM Disease Gene | 143 |
| 3208 | SLC25A12 | solute carrier family 25 member 12 | 2 | TransporterOMIM Disease Gene | 143 |
| 3209 | TBL2 | transducin beta like 2 | 7 | Experimental GO EvidenceSwiss-Prot Reviewed | 143 |
| 3210 | AGK | acylglycerol kinase | 7 | KinaseOMIM Disease Gene | 142 |
| 3211 | APOM | apolipoprotein M | 6 | TransporterExperimental GO Evidence | 142 |
| 3212 | APPL1 | adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | 3 | OMIM Disease GeneExperimental GO Evidence | 142 |
| 3213 | BRCC3 | BRCA1/BRCA2-containing complex subunit 3 | X | DNA RepairHub Gene | 142 |
| 3214 | CCL22 | C-C motif chemokine ligand 22 | 16 | Hub GeneExperimental GO Evidence | 142 |
| 3215 | CD33 | CD33 molecule | 19 | FDA Approved TargetExperimental GO Evidence | 142 |
| 3216 | DCP1A | decapping mRNA 1A | 3 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3217 | DEFB103B | defensin beta 103B | 8 | Swiss-Prot Reviewed | 142 |
| 3218 | EDA | ectodysplasin A | X | Highly ConstrainedOMIM Disease Gene | 142 |
| 3219 | ETV4 | ETS variant transcription factor 4 | 17 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3220 | EXT1 | exostosin glycosyltransferase 1 | 8 | Highly ConstrainedTumor Suppressor | 142 |
| 3221 | FAT1 | FAT atypical cadherin 1 | 4 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3222 | GGCX | gamma-glutamyl carboxylase | 2 | FDA Approved TargetOMIM Disease Gene | 142 |
| 3223 | KRT6A | keratin 6A | 12 | OMIM Disease GeneExperimental GO Evidence | 142 |
| 3224 | MARK3 | microtubule affinity regulating kinase 3 | 14 | KinaseOMIM Disease Gene | 142 |
| 3225 | NCAPD2 | non-SMC condensin I complex subunit D2 | 12 | OMIM Disease GeneExperimental GO Evidence | 142 |
| 3226 | NHERF2 | NHERF family PDZ scaffold protein 2 | 16 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3227 | NUP88 | nucleoporin 88 | 17 | TransporterOMIM Disease Gene | 142 |
| 3228 | P2RY2 | purinergic receptor P2Y2 | 11 | ReceptorFDA Approved Target | 142 |
| 3229 | PDCD11 | programmed cell death 11 | 10 | Hub GeneExperimental GO Evidence | 142 |
| 3230 | PKN2 | protein kinase N2 | 1 | KinaseExperimental GO Evidence | 142 |
| 3231 | POLR2J | RNA polymerase II subunit J | 7 | Hub GeneExperimental GO Evidence | 142 |
| 3232 | PRKAR2B | protein kinase cAMP-dependent type II regulatory subunit beta | 7 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3233 | PSCA | prostate stem cell antigen | 8 | Early PipelineExperimental GO Evidence | 142 |
| 3234 | RCAN1 | regulator of calcineurin 1 | 21 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3235 | RGS4 | regulator of G protein signaling 4 | 1 | OMIM Disease GeneExperimental GO Evidence | 142 |
| 3236 | SAFB2 | scaffold attachment factor B2 | 19 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3237 | SPAG9 | sperm associated antigen 9 | 17 | Highly ConstrainedExperimental GO Evidence | 142 |
| 3238 | SVIL | supervillin | 10 | OMIM Disease GeneExperimental GO Evidence | 142 |
| 3239 | TSR1 | TSR1 ribosome maturation factor | 17 | Hub GeneExperimental GO Evidence | 142 |
| 3240 | UPF3B | UPF3B regulator of nonsense mediated mRNA decay | X | Highly ConstrainedHub Gene | 142 |
| 3241 | VAV2 | vav guanine nucleotide exchange factor 2 | 9 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3242 | WDR6 | WD repeat domain 6 | 3 | Experimental GO EvidenceSwiss-Prot Reviewed | 142 |
| 3243 | ACVR2A | activin A receptor type 2A | 2 | Highly ConstrainedKinase | 141 |
| 3244 | ADORA2B | adenosine A2b receptor | 17 | ReceptorFDA Approved Target | 141 |
| 3245 | AMBP | alpha-1-microglobulin/bikunin precursor | 9 | Experimental GO EvidenceSwiss-Prot Reviewed | 141 |
| 3246 | AMBRA1 | autophagy and beclin 1 regulator 1 | 11 | Hub GeneTumor Suppressor | 141 |
| 3247 | APOD | apolipoprotein D | 3 | TransporterExperimental GO Evidence | 141 |
| 3248 | C2 | complement C2 | 6 | ProteaseOMIM Disease Gene | 141 |
| 3249 | CHMP2B | charged multivesicular body protein 2B | 3 | TransporterOMIM Disease Gene | 141 |
| 3250 | CTSC | cathepsin C | 11 | ProteaseFDA Approved Target | 141 |